Filed: 5/15/2025ACC: 0001012975-25-000242
📋 What this filing means
PERCEPTIVE ADVISORS LLC filed this quarterly 13F‑HR report disclosing 86 equity positions with a total reported market value of $2.84B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
86
Positions
$2.84B
Total AUM (reported)
240.57M
Total Shares
Allocation by class
COM$1.83B64.6%
SPONSORED ADS$460.80M16.2%
COMMON STOCK$202.86M7.1%
COM NEW$198.04M7.0%
SHS$47.30M1.7%
COM PAR $.01$38.85M1.4%
SPONSORED ADR$35.22M1.2%
Portfolio Concentration
Top 3$783.83M27.6%
4–10$771.22M27.2%
11–25$643.36M22.7%
Rest$639.79M22.5%
Top 3 weight
27.6%
Top 10 weight
54.8%
Voting Authority Distribution
Total shares with voting rights: 240.57M
Sole
Full voting authority
240.57M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole86
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings86
Rows:
VERONA PHARMA PLC
SOLEShares6.56M
TypeSH
Market value$416.71M
14.68%
Sole
6.56M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares2.93M
TypeSH
Market value$191.98M
6.76%
Sole
2.93M
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares21.46M
TypeSH
Market value$175.15M
6.17%
Sole
21.46M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares7.05M
TypeSH
Market value$155.04M
5.46%
Sole
7.05M
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares2.55M
TypeSH
Market value$134.99M
4.76%
Sole
2.55M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares1.63M
TypeSH
Market value$115.88M
4.08%
Sole
1.63M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares1.51M
TypeSH
Market value$107.65M
3.79%
Sole
1.51M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares786.36K
TypeSH
Market value$103.74M
3.66%
Sole
786.36K
Shared
0.00
None
0.00
MEIRAGTX HLDGS PLC
SOLEShares12.58M
TypeSH
Market value$85.25M
3.00%
Sole
12.58M
Shared
0.00
None
0.00
ARTIVION INC
SOLEShares2.79M
TypeSH
Market value$68.67M
2.42%
Sole
2.79M
Shared
0.00
None
0.00
ALDEYRA THERAPEUTICS INC
SOLEShares9.28M
TypeSH
Market value$53.34M
1.88%
Sole
9.28M
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares1.09M
TypeSH
Market value$52.77M
1.86%
Sole
1.09M
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares4.13M
TypeSH
Market value$49.67M
1.75%
Sole
4.13M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares2.84M
TypeSH
Market value$48.61M
1.71%
Sole
2.84M
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares11.91M
TypeSH
Market value$44.05M
1.55%
Sole
11.91M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares3.04M
TypeSH
Market value$43.72M
1.54%
Sole
3.04M
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares12.71M
TypeSH
Market value$42.33M
1.49%
Sole
12.71M
Shared
0.00
None
0.00
IMMATICS N.V
SOLEShares9.38M
TypeSH
Market value$42.32M
1.49%
Sole
9.38M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares1.12M
TypeSH
Market value$41.95M
1.48%
Sole
1.12M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares355.11K
TypeSH
Market value$41.42M
1.46%
Sole
355.11K
Shared
0.00
None
0.00
INSMED INC
SOLEShares509.30K
TypeSH
Market value$38.85M
1.37%
Sole
509.30K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.31M
TypeSH
Market value$37.32M
1.32%
Sole
2.31M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares980.89K
TypeSH
Market value$37.15M
1.31%
Sole
980.89K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares59.51K
TypeSH
Market value$35.22M
1.24%
Sole
59.51K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares6.49M
TypeSH
Market value$34.63M
1.22%
Sole
6.49M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VERONA PHARMA PLCSOLE | SPONSORED ADS | 6.56M | SH | $416.71M 14.68% | 6.56M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 2.93M | SH | $191.98M 6.76% | 2.93M | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 21.46M | SH | $175.15M 6.17% | 21.46M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 7.05M | SH | $155.04M 5.46% | 7.05M | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 2.55M | SH | $134.99M 4.76% | 2.55M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 1.63M | SH | $115.88M 4.08% | 1.63M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 1.51M | SH | $107.65M 3.79% | 1.51M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 786.36K | SH | $103.74M 3.66% | 786.36K | 0.00 | 0.00 |
MEIRAGTX HLDGS PLCSOLE | COM | 12.58M | SH | $85.25M 3.00% | 12.58M | 0.00 | 0.00 |
ARTIVION INCSOLE | COM | 2.79M | SH | $68.67M 2.42% | 2.79M | 0.00 | 0.00 |
ALDEYRA THERAPEUTICS INCSOLE | COM | 9.28M | SH | $53.34M 1.88% | 9.28M | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 1.09M | SH | $52.77M 1.86% | 1.09M | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 4.13M | SH | $49.67M 1.75% | 4.13M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 2.84M | SH | $48.61M 1.71% | 2.84M | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 11.91M | SH | $44.05M 1.55% | 11.91M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 3.04M | SH | $43.72M 1.54% | 3.04M | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | COM | 12.71M | SH | $42.33M 1.49% | 12.71M | 0.00 | 0.00 |
IMMATICS N.VSOLE | SHS | 9.38M | SH | $42.32M 1.49% | 9.38M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 1.12M | SH | $41.95M 1.48% | 1.12M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 355.11K | SH | $41.42M 1.46% | 355.11K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 509.30K | SH | $38.85M 1.37% | 509.30K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.31M | SH | $37.32M 1.32% | 2.31M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 980.89K | SH | $37.15M 1.31% | 980.89K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 59.51K | SH | $35.22M 1.24% | 59.51K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 6.49M | SH | $34.63M 1.22% | 6.49M | 0.00 | 0.00 |
Page 1 of 4